当前位置: X-MOL 学术Acta Pharmacol. Sin. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Nicotine pretreatment alleviates MK-801-induced behavioral and cognitive deficits in mice by regulating Pdlim5/CRTC1 in the PFC
Acta Pharmacologica Sinica ( IF 6.9 ) Pub Date : 2022-08-29 , DOI: 10.1038/s41401-022-00974-8
Qian Wang 1 , Meng-Wei Wang 2 , Yan-Yun Sun 2 , Xiao-Yan Hu 1 , Pan-Pan Geng 1 , Hui Shu 2 , Xiao-Na Wang 2 , Hao Wang 1 , Jun-Fang Zhang 3, 4 , Hong-Qiang Cheng 5 , Wei Wang 6 , Xin-Chun Jin 1, 2
Affiliation  

Increasing evidence shows that smoking-obtained nicotine is indicated to improve cognition and mitigate certain symptoms of schizophrenia. In this study, we investigated whether chronic nicotine treatment alleviated MK-801-induced schizophrenia-like symptoms and cognitive impairment in mice. Mice were injected with MK-801 (0.2 mg/kg, i.p.), and the behavioral deficits were assessed using prepulse inhibition (PPI) and T-maze tests. We showed that MK-801 caused cognitive impairment accompanied by increased expression of PDZ and LIM domain 5 (Pdlim5), an adaptor protein that is critically associated with schizophrenia, in the prefrontal cortex (PFC). Pretreatment with nicotine (0.2 mg · kg−1 · d−1, s.c., for 2 weeks) significantly ameliorated MK-801-induced schizophrenia-like symptoms and cognitive impairment by reversing the increased Pdlim5 expression levels in the PFC. In addition, pretreatment with nicotine prevented the MK-801-induced decrease in CREB-regulated transcription coactivator 1 (CRTC1), a coactivator of CREB that plays an important role in cognition. Furthermore, MK-801 neither induced schizophrenia-like behaviors nor decreased CRTC1 levels in the PFC of Pdlim5−/− mice. Overexpression of Pdlim5 in the PFC through intra-PFC infusion of an adreno-associated virus AAV-Pdlim5 induced significant schizophrenia-like symptoms and cognitive impairment. In conclusion, chronic nicotine treatment alleviates schizophrenia-induced memory deficits in mice by regulating Pdlim5 and CRTC1 expression in the PFC.



中文翻译:


尼古丁预处理通过调节 PFC 中的 Pdlim5/CRTC1 减轻 MK-801 诱导的小鼠行为和认知缺陷



越来越多的证据表明,通过吸烟获得的尼古丁可以改善认知并减轻精神分裂症的某些症状。在这项研究中,我们研究了长期尼古丁治疗是否可以减轻 MK-801 诱导的小鼠精神分裂症样症状和认知障碍。给小鼠注射 MK-801(0.2 mg/kg,腹腔注射),并使用前脉冲抑制 (PPI) 和 T 迷宫测试评估行为缺陷。我们发现,MK-801 会导致认知障碍,并伴有前额皮质 (PFC) 中 PDZ 和 LIM 结构域 5 (Pdlim5) 的表达增加,Pdlim5 是一种与精神分裂症密切相关的接头蛋白。尼古丁预处理(0.2 mg·kg -1 · d -1 ,皮下注射,持续 2 周)通过逆转 PFC 中增加的 Pdlim5 表达水平,显着改善了 MK-801 诱导的精神分裂症样症状和认知障碍。此外,尼古丁预处理可防止 MK-801 诱导的 CREB ​​调节转录共激活因子 1 (CRTC1) 减少,CRTC1 是 CREB ​​的共激活因子,在认知中发挥重要作用。此外,MK-801 既不会诱导 Pdlim5 −/−小鼠的精神分裂症样行为,也不会降低 PFC 中的 CRTC1 水平。通过在 PFC 内输注肾上腺相关病毒 AAV-Pdlim5,Pdlim5 在 PFC 中过度表达,诱导显着的精神分裂症样症状和认知障碍。总之,长期尼古丁治疗通过调节 PFC 中 Pdlim5 和 CRTC1 的表达来减轻精神分裂症引起的小鼠记忆缺陷。

更新日期:2022-08-29
down
wechat
bug